---
title: "Bioxytran Delays Annual 10-K Filing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281395210.md"
description: "Bioxytran Delays Annual 10-K Filing"
datetime: "2026-04-01T15:33:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281395210.md)
  - [en](https://longbridge.com/en/news/281395210.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281395210.md)
generator: "portal-rs"
---

# Bioxytran Delays Annual 10-K Filing

Bioxytran Delays Annual 10-K Filing

### Related Stocks

- [BIXT.US](https://longbridge.com/en/quote/BIXT.US.md)

## Related News & Research

- [Bioxytran reports functional gains in first CIDP patient treated with PLICID galectin antagonist](https://longbridge.com/en/news/295525258.md)
- [Bioxytran says Phase 2 trial of ProLectin-M drives SARS-CoV-2 viral load below detection by day seven](https://longbridge.com/en/news/294811633.md)
- [What Unchanged Risk Factors in American Eagle’s 2025 10-K Mean for Investors](https://longbridge.com/en/news/298794944.md)
- [Credo Technology Risk Profile Unchanged: Investors Must Rely on May 2026 Form 10-K Disclosures](https://longbridge.com/en/news/297998236.md)
- [Londax delays annual 10-K filing as audit takes longer than expected](https://longbridge.com/en/news/297554052.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**